Cognition Therapeutics, Inc.Cognition Therapeutics, Inc.Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc.

No trades
See on Supercharts

Cognition Therapeutics, Inc. stock forum

๏ปฟ
CGTX what's going on? we can't seem to prosper past .70 cents

CGTX Positive results from the Phase 2 study on Lewy Body Dementia are in! ๐Ÿš€ We're hopeful for FDA Fast Track approval to kick off Phase 3 soon. ๐ŸŽฏ Target prices are looking incredible: $1.50 to $22.00, with upgrades and fresh targets on the horizon. Did you know? Around 1.4 million people in the U.S. suffer from Lewy Body Dementia, costing $32 billion annually. Phase 3 is just around the corner in 2025, and with $29 million in cash and NIH funding, weโ€™re good until 2026 to complete our studies. It's only a matter of time before things take offโ€”2025 is going to be our year! ๐ŸŒŸ

CGTX I'm expecting the price to hit 2 today. My average cost per share is 0.83, and I hold 30,000 shares. I'm planning to sell 10,000 shares when the price reaches 1.7, and I'll keep the remaining 20,000 shares as a long-term investment since this stock looks very promising for the future.
Snapshot

CGTX we going to the moon with this one ๐Ÿš€๐Ÿš€๐Ÿš€